CorMatrix won CE Mark approval to introduce its CorMatrix CanGaroo ECM Envelope in the European Union, a device used to house implantable cardiac devices such as pacemakers and cardioverter defibrillators. It works to attract patient’s own cells and promote healing processes around the implanted electronic device.
While it’s named CanGaroo, don’t be deceived, as it’s actually made from an extracellular matrix that was prepared from pig tissue. The company touts this as the major benefit of their envelope over other similar devices that are typically made of synthetic materials. Because of the natural origin of the envelope, CorMatrix claims that it does not trigger an inflammatory response that often leads to scar tissue forming around the implant.
From the product page:
- CanGaroo® device remodels into vascularized tissue
- Stabilizes CIED to restrict migration
- Supports and reinforces the pocket
- CIEDs are easily removed from remodeled pocket
- Vascularized tissue pocket enhances patient comfort
Product page: CorMatrix CanGaroo…
Press release: CorMatrix® CanGaroo® ECM® Envelope Receives CE Mark Approval…